Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
User-agent: * Disallow: /wp-admin/ Allow: /wp-admin/admin-ajax.php Sitemap: |
Title | Pasithea – We are a Biotech Company at the forefront of research into mental health and brain |
Description | We are at the forefront of research focusing on development of therapies for diseases of the Pasithea Mission Pipeline Our Team Leadership Advisory Board Investors News Contact Menu Mission Pipeline Our Team Leadership Advisory Board Investors New |
Keywords | N/A |
WebSite | pasithea.com |
Host IP | 149.255.58.21 |
Location | United Kingdom |
Site | Rank |
US$11,457,701
Last updated: 2023-05-10 06:57:42
pasithea.com has Semrush global rank of 923,772. pasithea.com has an estimated worth of US$ 11,457,701, based on its estimated Ads revenue. pasithea.com receives approximately 1,322,043 unique visitors each day. Its web server is located in United Kingdom, with IP address 149.255.58.21. According to SiteAdvisor, pasithea.com is safe to visit. |
Purchase/Sale Value | US$11,457,701 |
Daily Ads Revenue | US$10,577 |
Monthly Ads Revenue | US$317,291 |
Yearly Ads Revenue | US$3,807,483 |
Daily Unique Visitors | 88,137 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
pasithea.com. | A | 8599 | IP: 149.255.58.21 |
pasithea.com. | NS | 3600 | NS Record: ns22.domaincontrol.com. |
pasithea.com. | NS | 3600 | NS Record: ns21.domaincontrol.com. |
pasithea.com. | MX | 3600 | MX Record: 0 pasithea-com.mail.protection.outlook.com. |
pasithea.com. | MX | 3600 | MX Record: 20 mx1.123-reg.co.uk. |
pasithea.com. | MX | 3600 | MX Record: 10 mx0.123-reg.co.uk. |
pasithea.com. | TXT | 8600 | TXT Record: v=spf1 include:spf.protection.outlook.com -all |
pasithea.com. | TXT | 8600 | TXT Record: MS=ms41034106 |
Pasithea Mission Pipeline Our Team Leadership Advisory Board Investors News Contact Menu Mission Pipeline Our Team Leadership Advisory Board Investors News Contact We are at the forefront of research focusing on development of therapies for diseases of the central nervous system (CNS). With an experienced team of experts in the fields of neuroscience and pharmacology, Pasithea is developing new molecular entities for the treatment of CNS disorders, including Amyotrophic Lateral Sclerosis (ALS) and Multiple Sclerosis, Neurofibromatosis type 1 and Noonan syndrome. Our Focus Our research on therapies is currently focused on developing treatment options for: Neurofibromatosis Type 1 NF1 is part of a group of conditions known as neurocutaneous disorders that affect the skin and the nervous system. NF1 causes tumor growth along nerves in the skin, brain, near the spinal cord and other parts of the body. These tumors are usually benign (non-cancerous), however they cause a range of symptoms |
HTTP/1.1 301 Moved Permanently Date: Tue, 02 Nov 2021 08:23:36 GMT Server: Apache X-Redirect-By: WordPress Upgrade: h2,h2c Connection: Upgrade Location: https://pasithea.com/ Content-Type: text/html; charset=UTF-8 |
Domain Name: PASITHEA.COM Registry Domain ID: 1618863200_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.123-reg.co.uk Registrar URL: http://www.meshdigital.com Updated Date: 2021-03-22T10:23:45Z Creation Date: 2010-10-04T18:51:35Z Registry Expiry Date: 2022-10-04T18:51:35Z Registrar: 123-Reg Limited Registrar IANA ID: 1515 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: NS21.DOMAINCONTROL.COM Name Server: NS22.DOMAINCONTROL.COM DNSSEC: unsigned >>> Last update of whois database: 2021-09-20T16:31:50Z <<< |